Global Chronic Pain Market Overview:
Global Chronic Pain Market is expected to grow at a significant rate during the forecast period 2026-2035, with 2025 as the base year.
Global Chronic Pain Market Report 2026 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2026-2035, with base year as 2025. This research study of Chronic Pain involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Chronic Pain Market:
The Chronic Pain Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Chronic Pain Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Chronic Pain Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Chronic Pain market has been segmented into:
Opioids
Non-steroidal anti-inflammatory drugs (NSAIDS
By Application, Chronic Pain market has been segmented into:
Neuropathic pain
Arthritis pain
Chronic back pain
Cancer pain
Migraine
Fibromyalgia
and Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Chronic Pain market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Chronic Pain market.
Top Key Players Covered in Chronic Pain market are:
Pfizer Inc.
Johnson & Johnson
GlaxoSmithKline PLC
Bayer AG
Novartis AG
Endo Pharmaceuticals
Bristol-Myers Squibb
Eli Lilly and Company
Teva Pharmaceutical Industries Ltd.
Reckitt Benckiser Group plc
Medtronic plc
AstraZeneca PLC
Becton
Dickinson and Company
AbbVie Inc.
Horizon Therapeutics
Mallinckrodt Pharmaceuticals
Zynerba Pharmaceuticals
Neurocrine Biosciences
Sorrento Therapeutics
Cypress Pharmaceutical
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Chronic Pain Market by Type
4.1 Chronic Pain Market Snapshot and Growth Engine
4.2 Chronic Pain Market Overview
4.3 Opioids
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Opioids: Geographic Segmentation Analysis
4.4 Non-steroidal anti-inflammatory drugs (NSAIDS
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Non-steroidal anti-inflammatory drugs (NSAIDS: Geographic Segmentation Analysis
Chapter 5: Chronic Pain Market by Application
5.1 Chronic Pain Market Snapshot and Growth Engine
5.2 Chronic Pain Market Overview
5.3 Neuropathic pain
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Neuropathic pain: Geographic Segmentation Analysis
5.4 Arthritis pain
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Arthritis pain: Geographic Segmentation Analysis
5.5 Chronic back pain
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Chronic back pain: Geographic Segmentation Analysis
5.6 Cancer pain
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Cancer pain: Geographic Segmentation Analysis
5.7 Migraine
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 Migraine: Geographic Segmentation Analysis
5.8 Fibromyalgia
5.8.1 Introduction and Market Overview
5.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.8.3 Key Market Trends, Growth Factors and Opportunities
5.8.4 Fibromyalgia: Geographic Segmentation Analysis
5.9 and Others
5.9.1 Introduction and Market Overview
5.9.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.9.3 Key Market Trends, Growth Factors and Opportunities
5.9.4 and Others: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Chronic Pain Market Share by Manufacturer (2023)
6.1.3 Industry BCG Matrix
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 PFIZER INC.
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Role of the Company in the Market
6.2.5 Sustainability and Social Responsibility
6.2.6 Operating Business Segments
6.2.7 Product Portfolio
6.2.8 Business Performance
6.2.9 Key Strategic Moves and Recent Developments
6.2.10 SWOT Analysis
6.3 JOHNSON & JOHNSON
6.4 GLAXOSMITHKLINE PLC
6.5 BAYER AG
6.6 NOVARTIS AG
6.7 ENDO PHARMACEUTICALS
6.8 BRISTOL-MYERS SQUIBB
6.9 ELI LILLY AND COMPANY
6.10 TEVA PHARMACEUTICAL INDUSTRIES LTD.
6.11 RECKITT BENCKISER GROUP PLC
6.12 MEDTRONIC PLC
6.13 ASTRAZENECA PLC
6.14 BECTON
6.15 DICKINSON AND COMPANY
6.16 ABBVIE INC.
6.17 HORIZON THERAPEUTICS
6.18 MALLINCKRODT PHARMACEUTICALS
6.19 ZYNERBA PHARMACEUTICALS
6.20 NEUROCRINE BIOSCIENCES
6.21 SORRENTO THERAPEUTICS
6.22 AND CYPRESS PHARMACEUTICAL
Chapter 7: Global Chronic Pain Market By Region
7.1 Overview
7.2. North America Chronic Pain Market
7.2.1 Key Market Trends, Growth Factors and Opportunities
7.2.2 Top Key Companies
7.2.3 Historic and Forecasted Market Size by Segments
7.2.4 Historic and Forecasted Market Size By Type
7.2.4.1 Opioids
7.2.4.2 Non-steroidal anti-inflammatory drugs (NSAIDS
7.2.5 Historic and Forecasted Market Size By Application
7.2.5.1 Neuropathic pain
7.2.5.2 Arthritis pain
7.2.5.3 Chronic back pain
7.2.5.4 Cancer pain
7.2.5.5 Migraine
7.2.5.6 Fibromyalgia
7.2.5.7 and Others
7.2.6 Historic and Forecast Market Size by Country
7.2.6.1 US
7.2.6.2 Canada
7.2.6.3 Mexico
7.3. Eastern Europe Chronic Pain Market
7.3.1 Key Market Trends, Growth Factors and Opportunities
7.3.2 Top Key Companies
7.3.3 Historic and Forecasted Market Size by Segments
7.3.4 Historic and Forecasted Market Size By Type
7.3.4.1 Opioids
7.3.4.2 Non-steroidal anti-inflammatory drugs (NSAIDS
7.3.5 Historic and Forecasted Market Size By Application
7.3.5.1 Neuropathic pain
7.3.5.2 Arthritis pain
7.3.5.3 Chronic back pain
7.3.5.4 Cancer pain
7.3.5.5 Migraine
7.3.5.6 Fibromyalgia
7.3.5.7 and Others
7.3.6 Historic and Forecast Market Size by Country
7.3.6.1 Bulgaria
7.3.6.2 The Czech Republic
7.3.6.3 Hungary
7.3.6.4 Poland
7.3.6.5 Romania
7.3.6.6 Rest of Eastern Europe
7.4. Western Europe Chronic Pain Market
7.4.1 Key Market Trends, Growth Factors and Opportunities
7.4.2 Top Key Companies
7.4.3 Historic and Forecasted Market Size by Segments
7.4.4 Historic and Forecasted Market Size By Type
7.4.4.1 Opioids
7.4.4.2 Non-steroidal anti-inflammatory drugs (NSAIDS
7.4.5 Historic and Forecasted Market Size By Application
7.4.5.1 Neuropathic pain
7.4.5.2 Arthritis pain
7.4.5.3 Chronic back pain
7.4.5.4 Cancer pain
7.4.5.5 Migraine
7.4.5.6 Fibromyalgia
7.4.5.7 and Others
7.4.6 Historic and Forecast Market Size by Country
7.4.6.1 Germany
7.4.6.2 UK
7.4.6.3 France
7.4.6.4 Netherlands
7.4.6.5 Italy
7.4.6.6 Russia
7.4.6.7 Spain
7.4.6.8 Rest of Western Europe
7.5. Asia Pacific Chronic Pain Market
7.5.1 Key Market Trends, Growth Factors and Opportunities
7.5.2 Top Key Companies
7.5.3 Historic and Forecasted Market Size by Segments
7.5.4 Historic and Forecasted Market Size By Type
7.5.4.1 Opioids
7.5.4.2 Non-steroidal anti-inflammatory drugs (NSAIDS
7.5.5 Historic and Forecasted Market Size By Application
7.5.5.1 Neuropathic pain
7.5.5.2 Arthritis pain
7.5.5.3 Chronic back pain
7.5.5.4 Cancer pain
7.5.5.5 Migraine
7.5.5.6 Fibromyalgia
7.5.5.7 and Others
7.5.6 Historic and Forecast Market Size by Country
7.5.6.1 China
7.5.6.2 India
7.5.6.3 Japan
7.5.6.4 South Korea
7.5.6.5 Malaysia
7.5.6.6 Thailand
7.5.6.7 Vietnam
7.5.6.8 The Philippines
7.5.6.9 Australia
7.5.6.10 New Zealand
7.5.6.11 Rest of APAC
7.6. Middle East & Africa Chronic Pain Market
7.6.1 Key Market Trends, Growth Factors and Opportunities
7.6.2 Top Key Companies
7.6.3 Historic and Forecasted Market Size by Segments
7.6.4 Historic and Forecasted Market Size By Type
7.6.4.1 Opioids
7.6.4.2 Non-steroidal anti-inflammatory drugs (NSAIDS
7.6.5 Historic and Forecasted Market Size By Application
7.6.5.1 Neuropathic pain
7.6.5.2 Arthritis pain
7.6.5.3 Chronic back pain
7.6.5.4 Cancer pain
7.6.5.5 Migraine
7.6.5.6 Fibromyalgia
7.6.5.7 and Others
7.6.6 Historic and Forecast Market Size by Country
7.6.6.1 Turkey
7.6.6.2 Bahrain
7.6.6.3 Kuwait
7.6.6.4 Saudi Arabia
7.6.6.5 Qatar
7.6.6.6 UAE
7.6.6.7 Israel
7.6.6.8 South Africa
7.7. South America Chronic Pain Market
7.7.1 Key Market Trends, Growth Factors and Opportunities
7.7.2 Top Key Companies
7.7.3 Historic and Forecasted Market Size by Segments
7.7.4 Historic and Forecasted Market Size By Type
7.7.4.1 Opioids
7.7.4.2 Non-steroidal anti-inflammatory drugs (NSAIDS
7.7.5 Historic and Forecasted Market Size By Application
7.7.5.1 Neuropathic pain
7.7.5.2 Arthritis pain
7.7.5.3 Chronic back pain
7.7.5.4 Cancer pain
7.7.5.5 Migraine
7.7.5.6 Fibromyalgia
7.7.5.7 and Others
7.7.6 Historic and Forecast Market Size by Country
7.7.6.1 Brazil
7.7.6.2 Argentina
7.7.6.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Chronic Pain Scope:
|
Report Data
|
Chronic Pain Market
|
|
Chronic Pain Market Size in 2025
|
USD XX million
|
|
Chronic Pain CAGR 2025 - 2032
|
XX%
|
|
Chronic Pain Base Year
|
2024
|
|
Chronic Pain Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Pfizer Inc., Johnson & Johnson, GlaxoSmithKline PLC, Bayer AG, Novartis AG, Endo Pharmaceuticals, Bristol-Myers Squibb, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Reckitt Benckiser Group plc, Medtronic plc, AstraZeneca PLC, Becton, Dickinson and Company, AbbVie Inc., Horizon Therapeutics, Mallinckrodt Pharmaceuticals, Zynerba Pharmaceuticals, Neurocrine Biosciences, Sorrento Therapeutics, and Cypress Pharmaceutical.
|
|
Key Segments
|
By Type
Opioids
Non-steroidal anti-inflammatory drugs (NSAIDS
By Applications
Neuropathic pain
Arthritis pain
Chronic back pain
Cancer pain
Migraine
Fibromyalgia
and Others
|
